Antibody-expressing Oncolytic Virus

Jerrycret6827 Dec, 2023Technology

Recently, recombinant monoclonal antibodies (mAbs) are one of the most powerful therapeutic classes in inflammatory diseases and oncology. However, a broader accessibility and implementation is limited by the high product cost and long-term need for frequent administration.